Rev.1 conjunctival vaccine: quality assurance and quality control
Saved in:
Main Authors: | Schreuer, D. (Vetoquinol Biotechnologie, Lure (France)), FAO, Rome (Italy). Animal Production and Health Div. eng, FAO/WHO/OIE Round Table on the Use of Rev.1 Vaccine in Small Ruminants and Cattle eng 21-22 Sep 1995 Maisons-Alfort (France), Garin-Bastuji, B. (ed.), Benkirane, A. (ed.), Centre National d'Etudes Veterinaires et Alimentaires, Maisons-Alfort (France) fre |
---|---|
Format: | Texto biblioteca |
Language: | |
Published: |
Maisons-Alfort (France) CNEVA
1995
|
Subjects: | BRUCELLA, VACCINES, QUALITY ASSURANCE, QUALITY CONTROLS, VACCIN, ASSURANCE QUALITE, VACUNA, GARANTIA DE CALIDAD, CONTROLE DE QUALITE, CONTROL DE CALIDAD, |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The quality assurance of living Brucella vaccines, the French experience with the Rev.1 vaccine
by: Garin-Bastuji, B., et al.
Published: (1995) -
Production and quality control of vaccine for brucellosis with a specific emphasis on Rev.1 vaccine
by: Milward, F.W. (Rhone Merieux, Lyon (France)), et al.
Published: (1995) -
Efficacy and advantages of the Rev.1 conjunctival vaccine against B. melitensis infection, as evaluated in standard controlled conditions
by: Verger, J.M. (Institut National de la Recherche Agronomique, Nouzilly (France). Lab. de Pathologie Infectieuse et d'Immunologie), et al.
Published: (1995) -
Live vaccines: virulence, immunogenicity protection and safety: historical, theoretical and practical considerations applied to the Brucella melitensis Rev.1 vaccine
by: Plommet, M. (Institut National de la Recherche Agronomique, Paris (France)), et al.
Published: (1995) -
Brucella melitensis Rev.1 vaccine: stability of markers, residual virulence and immunogenicity in mice
by: Bosseray, N. (Institut National de la Recherche Agronomique, Nouzilly (France). Lab. de Pathologie Infectieuse et d'Immunologie), et al.
Published: (1995)